I think the first iteration of CRISPR/gene editing therapy for treating diseases (and possibly just plain human enhancement) will begin to go mainstream, simila

I think the first iteration of CRISPR/gene editing therapy for treating diseases (and possibly just plain human enhancement) will begin to go mainstream, similar to the rise of LASIK. But only for somatic cell editing - cells other than sperm/egg.